Virginia Clinic Tests Psilocybin for Cocaine Addiction

A groundbreaking addiction treatment is coming to southwest Virginia, offering new hope to people struggling with cocaine use disorder.

The National Institute on Drug Abuse awarded Carilion Clinic more than $600,000 to study whether psilocybin combined with therapy can reduce cocaine addiction. Dr. Albert Arias, the clinic's Chief of Psychiatry and a 25-year veteran in addiction medicine, will lead the research.

This isn't a shot in the dark. Researchers have explored psychedelic compounds as addiction treatments since the 1960s, with some success using substances like ibogaine. More recently, psilocybin has shown promise treating depression and anxiety, leading scientists to wonder if similar mechanisms might help people overcome addiction.

The study will examine whether the treatment is safe, well-tolerated, and shows early signs of effectiveness. Patients at Carilion Clinic will receive structured psychotherapy alongside carefully administered psilocybin doses.

Only one or two other facilities in the entire country currently offer this experimental treatment through research trials. For residents of Virginia and surrounding areas, this means accessing cutting-edge care without traveling across the country.

The Ripple Effect

The initial $600,000 grant could grow into something much bigger. If results prove promising, NIDA may award up to $3.5 million to support a larger clinical research phase. That expanded study could provide even more definitive answers about whether this approach works.

Dr. Arias brings both clinical expertise and academic rigor to the project through his dual role as a professor at Virginia Tech Carilion School of Medicine. His team will carefully track outcomes to determine if this novel approach could become a standard treatment option.

Cocaine addiction affects hundreds of thousands of Americans, and effective treatments remain limited. Traditional approaches help many people, but not everyone responds. New options could make the difference for those who haven't found success with existing therapies.

The research represents a broader shift in how scientists approach mental health and addiction treatment, reconsidering compounds once dismissed and applying modern scientific methods to evaluate their potential.

For people battling cocaine addiction in Virginia, this trial offers something invaluable: hope backed by serious science and federal funding.